iRhythm Technologies, Inc. (IRTC) Revenue History
Annual and quarterly revenue from 2013 to present
IRTC Revenue Over Time (2013–2025)
IRTC Revenue Growth History
12 of 12 years with positive growth- FY2013 revenue growth
- N/A
- FY2014 revenue growth
- +41.5%
- FY2015 revenue growth
- +66.2%
- FY2016 revenue growth
- +77.3%
- FY2017 revenue growth
- +54.7%
- FY2018 revenue growth
- +48.6%
- FY2019 revenue growth
- +45.7%
- FY2020 revenue growth
- +23.6%
- FY2021 revenue growth
- +21.7%
- FY2022 revenue growth
- +27.3%
- FY2023 revenue growth
- +19.9%
- FY2024 revenue growth
- +20.1%
- FY2025 revenue growth
- +26.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $199.4M | +25.7% |
| Q4 2025 | $208.9M | +27.1% |
| Q3 2025 | $192.9M | +30.7% |
| Q2 2025 | $186.7M | +26.1% |
| Q1 2025 | $158.7M | +20.3% |
| Q4 2024 | $164.3M | +24.0% |
| Q3 2024 | $147.5M | +18.4% |
| Q2 2024 | $148.0M | +19.3% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
IRTC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
IRTC Revenue Analysis (2013–2025)
Current Revenue & Growth
As of June 21, 2026, iRhythm Technologies, Inc. (IRTC) generated trailing twelve-month (TTM) revenue of $787.9 million, reflecting exceptional growth of +25.7% year-over-year. The most recent quarter (Q1 2026) recorded $199.4 million in revenue, down 4.5% sequentially.
Historical Growth Trajectory
IRTC's 5-year compound annual growth rate (CAGR) stands at +23.0%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +22.1% is below the 5-year average, signalling a growth deceleration in recent years. iRhythm Technologies, Inc.'s highest annual revenue of $747.1 million was recorded in 2025, an all-time high.
Revenue by Segment
IRTC's revenue is primarily driven by Commercial Payors (52%), Centers For Medicare And Medicaid (24%), and Healthcare Institutions (17%). With over half of revenue concentrated in Commercial Payors, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including ITGR (+6.0% YoY), INVA (+13.6% YoY), and BDX (+2.4% YoY) — IRTC has outperformed the peer group in revenue growth. Compare IRTC vs ITGR →
IRTC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IRTCCurrent | $788M | +25.7% | +23.0% | -4.9% | |
 ITGR | $1.8B | +6.0% | +11.5% | 11.3% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 BDX | $21.8B | +2.4% | +6.3% | 11.8% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
IRTC Historical Revenue Data (2013–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $747.1M | +26.2% | $527.3M | 70.6% | $-36,810,000 | -4.9% |
| 2024 | $591.8M | +20.1% | $407.5M | 68.9% | $-115,505,000 | -19.5% |
| 2023 | $492.7M | +19.9% | $331.8M | 67.3% | $-125,161,000 | -25.4% |
| 2022 | $410.9M | +27.3% | $281.6M | 68.5% | $-113,784,000 | -27.7% |
| 2021 | $322.8M | +21.7% | $213.6M | 66.2% | $-99,943,000 | -31.0% |
| 2020 | $265.2M | +23.6% | $194.9M | 73.5% | $-43,673,000 | -16.5% |
| 2019 | $214.6M | +45.7% | $162.1M | 75.5% | $-54,755,000 | -25.5% |
| 2018 | $147.3M | +48.6% | $108.5M | 73.7% | $-45,691,000 | -31.0% |
| 2017 | $99.1M | +54.7% | $70.9M | 71.5% | $-27,591,000 | -27.8% |
| 2016 | $64.1M | +77.3% | $43.2M | 67.4% | $-15,582,000 | -24.3% |
| 2015 | $36.1M | +66.2% | $21.4M | 59.3% | $-21,631,000 | -59.9% |
| 2014 | $21.7M | +41.5% | $11.2M | 51.3% | $-14,765,000 | -67.9% |
| 2013 | $15.4M | - | $6.5M | 42.4% | $-11,178,000 | -72.7% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IRTC — Frequently Asked Questions
Quick answers to the most common questions about buying IRTC stock.
Is IRTC's revenue growth accelerating or slowing?
IRTC revenue growth is accelerating. TTM revenue reached $788M, up +25.7% year-over-year — ahead of the 5-year CAGR of +23.0%. This indicates the business is expanding faster than its historical baseline.
What is IRTC's revenue history from 2013 to 2026?
iRhythm Technologies, Inc. (IRTC) revenue history spans 2013 to 2026. TTM revenue as of 2026 is $788M, growing at +25.7% YoY. The 5-year CAGR is +23.0%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is IRTC's long-term revenue growth rate (CAGR)?
iRhythm Technologies, Inc.'s 5-year revenue CAGR of +23.0% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +25.7% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for IRTC.
Why does IRTC's quarterly revenue fluctuate?
IRTC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. iRhythm Technologies, Inc.'s revenue data from 2013 to 2026 shows full historical quarterly detail on this page.
How is IRTC's revenue distributed by segment?
IRTC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does IRTC's revenue compare to industry peers?
iRhythm Technologies, Inc. (IRTC) with TTM revenue of $788M and +25.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.